Orasure Technologies (OSUR) Receives a Rating Update from a Top Analyst

By Austin Angelo

Canaccord Genuity analyst Mark Massaro maintained a Hold rating on Orasure Technologies (OSURResearch Report) yesterday and set a price target of $7. The company’s shares closed last Monday at $7.57, close to its 52-week low of $7.15.

Massaro commented:

“We stick with our HOLD rating and lower our PT from $9 to $7.”

According to TipRanks.com, Massaro is a top 100 analyst with an average return of 20.8% and a 64.0% success rate. Massaro covers the Healthcare sector, focusing on stocks such as HTG Molecular Diagnostics, Meridian Bioscience Inc, and Quanterix Corporation.

The word on The Street in general, suggests a Hold analyst consensus rating for Orasure Technologies with a $7 average price target.

See today’s analyst top recommended stocks >>

Orasure Technologies’ market cap is currently $467.3M and has a P/E ratio of 24.27. The company has a Price to Book ratio of 1.62.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic and collection devices and other technologies designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments.